BIOMARIN PHARMACEUTICAL INC

CUSIP: 09061GAH4 Class: Convertible Debt

AXA S.A.'s Holding History (CIK: 0000898427)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 771,000 Value ($000) $759 Avg Close — Range —
Q4 2023
Shares 771,000 Value ($000) $763 Avg Close — Range —
Q3 2023
Shares 771,000 Value ($000) $748 Avg Close — Range —
Q2 2023
Shares 4,530,000 Value ($000) $4,456 Avg Close — Range —
Q1 2023
Shares 4,530,000 Value ($000) $4,643 Avg Close — Range —
Q4 2022
Shares 4,530,000 Value ($000) $4,841 Avg Close — Range —
Q3 2022
Shares 7,430,000 Value ($000) $7,373 Avg Close — Range —
Q2 2022
Shares 7,430,000 Value ($000) $7,354 Avg Close — Range —
Q1 2022
Shares 8,430,000 Value ($000) $8,468 Avg Close — Range —
Q4 2021
Shares 8,430,000 Value ($000) $8,906 Avg Close — Range —
Q3 2021
Shares 10,590,000 Value ($000) $10,997 Avg Close — Range —
Q2 2021
Shares 10,590,000 Value ($000) $11,066 Avg Close — Range —
Q1 2021
Shares 10,590,000 Value ($000) $11,110 Avg Close — Range —
Q4 2020
Shares 10,590,000 Value ($000) $11,354 Avg Close — Range —
Q3 2020
Shares 8,320,000 Value ($000) $8,867 Avg Close — Range —
Q2 2020
Shares 2,980,000 Value ($000) $3,642 Avg Close — Range —